How does lebrikizumab compare to JAK inhibitors in terms of safety and efficacy for patients with atopic dermatitis?Featuring Pearl Kwong, MD | HCA Florida Orange Park HospitalJacksonville, Florida | Published July 01, 2025Loading...Related CMEView allRelated MediaPowered by Polaris TM